Read article – Quotes President Phil Hanlon ’77; Duane Compton, dean of the Geisel School of Medicine; and Lisa Marsch, director of the Center for Technology and Behavioral Health (CTBH) and professor of psychiatry and of the Dartmouth Institute for Health Policy and Clinical Practice; in a feature story about a recent conference Dartmouth hosted to address the country’s opioid epidemic. At the conference, Marsch presented the results of a six-month study of the crisis conducted by researchers at CTBH with funding from the National Institute on Drug Abuse.

Read article – An opinion piece by Kathy Kirkland, Geisel ’86, professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, about how facing worst-case scenarios in a safe environment can help people prepare themselves and practice how they might react.

Read article – As a guest on “Vermont Edition,” Michael Sateia, active emeritus professor of psychiatry, discusses the causes of sleeplessness, insomnia, and sleep apnea, and their profound effects.

Read article – Quotes Bill Hudenko, assistant professor of psychiatry and adjunct assistant professor of psychological and brain sciences, in an article about how researchers are now developing ways to use artificial intelligence to map out the relationship between factors that lead to suicide. Hudenko is working with researchers from the University of Vermont to develop a system for both suicide risk assessment and prevention by using an app he and his Dartmouth colleagues developed called Proxi, which aims to improve well-being for people with depression and other conditions.

Read article – An opinion piece by Kathy Kirkland, Geisel ’86, professor of medicine and of the Dartmouth Institute for Health Policy and Clinical Practice, regarding her experiences working in palliative care. “It’s funny how the world of palliative care, which each day brings us face-to-face with illness, with mortality, with heartbreak, is not a place of overwhelming sadness,” says Kirkland. “Each day, instead, we find (or perhaps we cocreate) meaning, and even joy in our work.”

Read article – Cites findings from The Dartmouth Atlas of Healthcare that show regions that spend more on treatment do not have better outcomes.

Read article – A video featuring Mariétou Ouayogodé, post-doctoral fellow at the Dartmouth Institute for Health Policy and Clinical Practice, where she discusses how the provision in the Affordable Care Act to remove cost sharing for preventive care visits created a shift in how Medicare pays, with a greater emphasis on prevention and managing chronic diseases, and less on treatment of acute illness.

Read article – Quotes Lisa Schwartz, professor of medicine, community and family medicine, and of the Dartmouth Institute for Health Policy and Clinical Practice, about a new study published in JAMA that found the rare cancer polycythemia vera got a mention on America’s oldest soap opera, “General Hospital,” because the drug company Incyte asked it to. Incyte’s only FDA-approved drug, ruxolitinib, happens to treat the cancer, and the “General Hospital” appearance was the company’s attempt to raise awareness about the rare disease — and possibly to sell more of its drug. With a message this subtle, “there’s no way you would ever know it was connected to the drug company,” says Schwartz, who was not involved in the study. “Your natural skepticism that comes up when you see advertising is totally down because you don’t know the drug company has any role in the message you’re getting.”